Target intelligence / Profile preview

Intestinal microbiota composition modulation

Molecular classification
Other
01

Overview

Intestinal microbiota composition modulation refers to the deliberate alteration—through diet, supplementation with specific microorganisms such as probiotics, prebiotic intake, or more targeted interventions like fecal microbiota transplantation—of the complex microbial communities residing in the gastrointestinal tract. This process aims to optimize host health by restoring balance within the gut ecosystem. A balanced and diverse gut microbiome is generally associated with positive health outcomes including proper nutrient metabolism and immune function; conversely, imbalances are linked to various diseases such as cardiometabolic disorders and inflammatory conditions. While this concept is central in both research and clinical practice for its therapeutic potential, it does not represent a single molecular target but rather an approach involving multiple species and mechanisms within an ecological system. Note: "Intestinal microbiota composition modulation" is not a discrete molecule/receptor/target but rather describes an intervention strategy affecting a complex community; thus it should be flagged as incorrect for use where molecular targets are required.

Other names
Gut microbiota modulationGut microbiome modulationModulation of intestinal microbiota compositionMicrobiota modulation
02

Mechanism of action

Restoration or alteration of microbial community structure and function through dietary intervention, supplementation with live microorganisms, or transplantation techniques

03

Biological functions

Nutrient metabolismImmune system development and regulationMaintenance of intestinal homeostasisModulation of inflammation
04

Disease associations

Cardiometabolic diseaseInflammationInfection (e.g., Clostridioides difficile infection)Other (broadly implicated in many diseases due to dysbiosis)
05

Safety considerations

Risk of infection from FMT procedures if not properly screened/processedUnpredictable individual responses to probiotics/prebiotics due to unique baseline microbiomes
06

Interacting drugs

Probiotics (various strains)

2 more in the full profile.

07

Biomarkers

Microbial diversity indices (e.g., Shannon index)Relative abundance of specific bacterial taxa associated with health or disease states

Beyond the preview

Go deeper on Intestinal microbiota composition modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal microbiota composition modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call